1. Numerous publications related to lung transplantation and advanced lung diseases
2. Track record of NIH awards to study novel therapies and diagnostic approaches
3. Past Chair, Pulmonary Transplantation Council, International Society of Heart and Lung Transplantation
4. 2010 Professional of the Year, named by the Cystic Fibrosis Research, Inc.
5. Ten years on the Editorial Board, The Journal of Heart and Lung Transplantation

1. Pulmonary Council Leader, Standard and Guidelines Committee, International Society of Heart and Lung Transplantation
2. Member, Medical Advisory Board, California Transplant Donor Network
3. Member, Thoracic Committee, United Network for Organ Sharing
4. Member, National Lung Review Board, United Network for Organ Sharing
5. Member, Membership and Professional Standards Committee, United Network for Organ Sharing
6. Developed the training curriculum for the longest standing lung transplant fellowship in the world

It has been my privilege and passion to work in the life-changing practice of organ transplantation. During my exciting career, including 11 years as Director of the Lung and Heart-Lung Transplant Program and founder of the Center for Advanced Lung Disease at Stanford University Medical Center, I saw first-hand the amazing and challenging aspects of transplantation and its effects on patients and transplant team members.

Today, I help transplant hospitals navigate the complex transplant environment to reach optimal outcomes.

It’s scary for anyone to hear the words, “you need a transplant.” But it’s just the beginning of a long and challenging journey. I provide timely information for patients, families, and transplant teams. I’m dedicated to helping all those on the journey find their way to success.

Questions to ask:

1. How many transplants have you done in the last year?
2. What is your 1 year survival rate? 3 year? 5 year? 10 year?
3. How long has the physician team worked together?
4. How long ago did the medical and surgical teams finish their training?
5. Will I be cared for primarily by a resident in training?
6. Will the nurse coordinator return my calls promptly?
7. How long is the average call back time?
8. What percentage of patients discharged from the hospital are sent home, as opposed to a long-term care facility?

For many years, Dr. Weill has advised companies and governmental bodies about any potential risk associated with various exposure types. Whether in the litigation setting or in the science policy arena, companies and scientific agencies call on Dr. Weill to provide the most current and accurate information.

EXPERTISE:

I provide expert opinion about occupational lung diseases to governmental bodies, companies, and in litigation settings I was chairman of The Monticello Conference on Elongated Mineral Particles: An Assessment of Health Effects, Definitions, and Research Priorities in October 2017

Dr. Weill works with companies in the transplantation and lung disease space in a variety of ways. Whether as a board member, scientific advisor, or angel investor, Dr. Weill lends his expertise to companies bringing innovative therapies to patients with serious medical conditions.

1. Interpretation of pulmonary function tests for clinical trials
2. Over-reading of pulmonary function tests for clinical trials and occupational health evaluations.